Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-27 21:26:30

expired found date

-

created at

2024-06-04 01:53:29

updated at

2025-12-27 15:16:35

Domain name statistics

length

9

crc

31960

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

162036

mp size raw text

1402

mp inner links count

0

mp inner links status

20 (imported)

Open Graph

title

description

image

site name

author

updated

2025-12-15 04:15:09

raw text

Spyre Therapeutics About Our Approach Pipeline Join Us Contact Us Investors And Media LinkedIn Twitter Engineering for new heights in the treatment of Inflammatory Bowel Disease Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches with the goal of creating Inflammatory Bowel Disease (IBD) therapies with uncompromising efficacy and convenience. Explore our PIPELINE ABOUT US Spyre is on a mission to improve treatment options for IBD. Our team has deep experience developing and commercializing treatments across a broad range of diseases, and is committed to helping patients living with IBD. MEET Our Team OUR APPROACH We are dedicated to researching potential improvements in efficacy and dosing through our investigational next-generation antibodies and rational combinations. Together with precision immunology approaches, we aspire to provide patients promising new treatment...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medycyna (36)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

1133

text words

191

text unique words

109

text lines

31

text sentences

10

text paragraphs

4

text words per sentence

19

text matched phrases

4

text matched dictionaries

3

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

2024-06-29 14:20:58

sitemap first import date

-

sitemap last import date

-